PARP Inhibition in the Management of Pancreatic Cancer
For this special edition of Oncology Today, I met with Dr Kim Reiss Binder from the Abramson Cancer Center in Philadelphia to discuss recently published and emerging research on the use of PARP inhibitors in pancreatic cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPARPPanc20).
